about
Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming AgentsOxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic RetinopathyEffects on specific promoter DNA methylation in zebrafish embryos and larvae following benzo[a]pyrene exposure.Molecular pathways and targets in prostate cancerEpigenetic DNA methylation of antioxidative stress regulator NRF2 in human prostate cancerEvolving Personalized Therapy for Castration-Resistant Prostate Cancer.The association between histone 3 lysine 27 trimethylation (H3K27me3) and prostate cancer: relationship with clinicopathological parameters.Methylation of Integrin α4 and E-Cadherin Genes in Human Prostate Cancer.Regulators of gene expression as biomarkers for prostate cancerDetection of galectins during malignant transformation of oral cells.Dynamic DNA methylation of matrix metalloproteinase-9 in the development of diabetic retinopathyThe Role of DNA Methylation in the Metabolic Memory Phenomenon Associated With the Continued Progression of Diabetic Retinopathy.Androgen receptor is negatively correlated with the methylation-mediated transcriptional repression of miR-375 in human prostate cancer cells.Oxidative stress, cancer, and sleep deprivation: is there a logical link in this association?The genomic landscape of prostate cancerDNA methylation: roles in rheumatoid arthritis.Global DNA hypomethylation in prostate cancer development and progression: a systematic review.Prostate cancer epigenome.Contribution of epigenetics in diabetic retinopathy.Prognostic Value of Protocadherin10 (PCDH10) Methylation in Serum of Prostate Cancer Patients.Long noncoding RNAs and tumorigenesis: genetic associations, molecular mechanisms, and therapeutic strategies.Identification of novel prostate cancer drivers using RegNetDriver: a framework for integration of genetic and epigenetic alterations with tissue-specific regulatory network.A Novel Role of Silibinin as a Putative Epigenetic Modulator in Human Prostate Carcinoma.DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects.miR-204 is dysregulated in metastatic prostate cancer in vitro.Epigenetic regulation of redox signaling in diabetic retinopathy: Role of Nrf2.Transforming Cancer Epigenetics Using Nutritive Approaches and Non-coding RNAs.Aberrant methylation of PCDH10 predicts worse biochemical recurrence-free survival in patients with prostate cancer after radical prostatectomy.Aberrant promoter methylation of the cadherin 13 gene in serum and its relationship with clinicopathological features of prostate cancer.Tea polyphenols for the prevention of UVB-induced skin cancer.Role of oxidative stress in epigenetic modification of MMP-9 promoter in the development of diabetic retinopathy.Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells.Exposure to Polycyclic Aromatic Hydrocarbons Leads to Non-monotonic Modulation of DNA and RNA (hydroxy)methylation in a Rat ModelEpigenetic suppression of the anti-aging gene KLOTHO in human prostate cancer cell lines
P2860
Q26744212-B71DB0DF-D2A2-43C5-9CF5-081638EE94A6Q29248994-3EF074FE-B80B-4F55-833C-DC3118400BA1Q33656372-951A6D9A-5AB8-4951-94FB-75931CBDA01BQ34365632-5BDCA646-A25A-4C7E-A586-E457B7CA2C1CQ34633152-A53F2A66-E197-4825-9D90-921D4703B55EQ34691562-193849CF-8C58-4AB9-AAEC-708201F21302Q35191267-95DA6570-711D-40AC-8417-80D08696BB55Q35572461-1B896DA2-65A2-44F6-BD5D-E343233B118CQ36439912-B94772A9-3C36-4447-BA87-FF79F2A519B3Q37222217-0841F3FD-13FC-4CB1-A1AA-8FE0CA18ED0BQ37280210-92312FB9-A415-4AAA-B1B4-8374E9A2391EQ37384357-D5D4584F-36CF-4091-A12F-9C4DB96E7FE4Q37404563-471F4E8A-9576-4CD8-BF67-C213A635BE0FQ38078311-DA011A7A-964E-4394-8FAB-D1397EBCC1B2Q38109474-0B10FF64-5C51-418D-B0DC-BB1BE6FDE672Q38197921-841DA27A-13B2-4E51-BD53-872EA931D984Q38266607-905E5532-9305-44CB-B6CE-3A7F663E0F33Q38271076-64A89A79-1CD9-4B8F-B084-1DE7701F8DCFQ38508141-E1DCC14D-E94C-42A7-9417-09E57D127B79Q38544056-394E6737-7F60-4778-9173-73F908535A02Q38639536-5BC52FC3-6028-40F7-ABCC-5570922C5AA5Q38657057-CB3005C4-50BA-40C5-B04A-2A7A5A9B2D80Q38723294-AA2808F6-DC44-4BFF-9ABE-1D8AE358BADBQ38833395-73C91E1E-EDFC-47EF-B1DF-4A7584B9E053Q38915627-98D3F4F9-94DF-4D30-9515-886596A26473Q39052777-416FB3A4-EFB6-4984-A163-3DDCDCD053D7Q39125760-897D95A9-E271-46A4-802F-9783742F273BQ42804809-58A9C3B3-BEEB-458F-B02E-53F56BC5DA4FQ44528110-8FC3F7A8-4F53-49DD-B864-D65DB87F12B3Q48168853-EE87F0D0-8C0C-4C50-A644-393A5EDF0747Q50931649-026E201B-D3FB-464D-843E-7614310362B7Q51341669-A2AC82D5-FEC4-4576-BABE-A3B023B39AF2Q57009882-75E120F5-E7B0-4C5D-BED0-F62B310E4C99Q58129319-9365ED0A-CC7C-4D13-8671-B26D785D4CB9
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Aberrant DNA methylation and prostate cancer.
@ast
Aberrant DNA methylation and prostate cancer.
@en
type
label
Aberrant DNA methylation and prostate cancer.
@ast
Aberrant DNA methylation and prostate cancer.
@en
prefLabel
Aberrant DNA methylation and prostate cancer.
@ast
Aberrant DNA methylation and prostate cancer.
@en
P2093
P2860
P1433
P1476
Aberrant DNA methylation and prostate cancer.
@en
P2093
Eric Buckles
John Estrada
Shahriar Koochekpour
Sunipa Majumdar
P2860
P304
P356
10.2174/138920211797904061
P577
2011-11-01T00:00:00Z